Overall rank by patents
#24,576
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 0 technology areas, active 2021–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search.
The verdict
Investigacion holds 11 US patents across 0 technology areas, rank #24,576 of 50,000 tracked assignees.
Investigacion Y Tecnologia De Uva De Mesa S.l. has been granted 11 US utility patents between 2021 and 2023, placing Investigacion Y Tecnologia De Uva De Mesa S.l. at rank #24,576 across all assignees tracked by PlainPatent. This portfolio spans 0 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.0 claims per patent. As a Foreign Corporation, Investigacion Y Tecnologia De Uva De Mesa S.l. is one of the more focused assignees in the PatentsView dataset. By volume, Investigacion sits between International Stem Cell Corporation (11 patents, rank #24,572) and Isolation Equipment Services Inc. (11 patents, rank #24,580) - the closest US assignees by grant volume. The composite Innovation Score of 10.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2023, with 11 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Investigacion Y Tecnologia De Uva De Mesa S.l.'s 1.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 0 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Investigacion Y Tecnologia De Uva De Mesa S.l. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
International Stem Cell Corporation
11 patents
International Textile Group, Inc.
11 patents
Intevep, S.A.
11 patents
Intuition Robotics, Ltd.
11 patents
Invicta Medical, Inc.
11 patents
Ioxus, Inc.
11 patents
Irwin Research and Development, Inc.
11 patents
Isolation Equipment Services Inc.
11 patents
Investigacion y Tecnologia de Uva de Mesa S.L.
11 patents
What this shows Investigacion holds 11 patents at rank #24,576, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Investigacion's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
11 Top 98% higher than 2% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 9 | 81.8% |
| 2023 | 2 | 18.2% |
Overall rank by patents
#24,576
Across all tracked assignees
10.7 out of 100
How to use this portfolio
Investigacion's 11 grants land it in the top 98% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.